Search details
1.
COBRAPed cohort: Do sensitization patterns differentiate children with severe asthma from those with a milder disease?
Pediatr Allergy Immunol
; 35(3): e14112, 2024 Mar.
Article
in English
| MEDLINE | ID: mdl-38520021
2.
Cefiderocol susceptibility of Achromobacter spp.: study of an accurately identified collection of 230 strains.
Ann Clin Microbiol Antimicrob
; 23(1): 54, 2024 Jun 17.
Article
in English
| MEDLINE | ID: mdl-38886694
3.
The French Compassionate Program of elexacaftor-tezacaftor-ivacaftor in people with cystic fibrosis with advanced lung disease and no F508del CFTR variant.
Eur Respir J
; 2023 Feb 16.
Article
in English
| MEDLINE | ID: mdl-36796836
4.
Cumulative Incidence and Risk Factors for Severe Coronavirus Disease 2019 in French People With Cystic Fibrosis.
Clin Infect Dis
; 75(12): 2135-2144, 2022 12 19.
Article
in English
| MEDLINE | ID: mdl-35475917
5.
Rapid Improvement after Starting Elexacaftor-Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis and Advanced Pulmonary Disease.
Am J Respir Crit Care Med
; 204(1): 64-73, 2021 07 01.
Article
in English
| MEDLINE | ID: mdl-33600738
6.
Biofilm Formation by Staphylococcus aureus in the Specific Context of Cystic Fibrosis.
Int J Mol Sci
; 24(1)2022 Dec 29.
Article
in English
| MEDLINE | ID: mdl-36614040
7.
Using chest CT scan and unsupervised machine learning for predicting and evaluating response to lumacaftor-ivacaftor in people with cystic fibrosis.
Eur Respir J
; 2021 Nov 18.
Article
in English
| MEDLINE | ID: mdl-34795038
8.
Non-tuberculous mycobacterial pulmonary diseases in France: an 8 years nationwide study.
BMC Infect Dis
; 21(1): 1165, 2021 Nov 17.
Article
in English
| MEDLINE | ID: mdl-34789152
9.
Real-Life Safety and Effectiveness of Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis.
Am J Respir Crit Care Med
; 201(2): 188-197, 2020 01 15.
Article
in English
| MEDLINE | ID: mdl-31601120
10.
Management of initial colonisations with Burkholderia species in France, with retrospective analysis in five cystic fibrosis Centres: a pilot study.
BMC Pulm Med
; 20(1): 159, 2020 Jun 05.
Article
in English
| MEDLINE | ID: mdl-32503487
11.
Mycobacterium chimaera Pulmonary Disease in Cystic Fibrosis Patients, France, 2010-2017.
Emerg Infect Dis
; 25(3): 611-613, 2019 03.
Article
in English
| MEDLINE | ID: mdl-30789330
12.
Gathering real-world compassionate data to expand eligibility for elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis with N1303K or other rare CFTR variants: a viewpoint.
Eur Respir J
; 63(1)2024 Jan.
Article
in English
| MEDLINE | ID: mdl-38242629
13.
Chronic Airway Colonization by Achromobacter xylosoxidans in Cystic Fibrosis Patients Is Not Sustained by Their Domestic Environment.
Appl Environ Microbiol
; 84(23)2018 12 01.
Article
in English
| MEDLINE | ID: mdl-30217850
14.
Impact of High Diversity of Achromobacter Populations within Cystic Fibrosis Sputum Samples on Antimicrobial Susceptibility Testing.
J Clin Microbiol
; 55(1): 206-215, 2017 01.
Article
in English
| MEDLINE | ID: mdl-27807149
15.
Transcription factors and miRNAs that regulate fetal to adult CFTR expression change are new targets for cystic fibrosis.
Eur Respir J
; 45(1): 116-28, 2015 Jan.
Article
in English
| MEDLINE | ID: mdl-25186262
16.
A French multicentric study and review of pulmonary Nocardia spp. in cystic fibrosis patients.
Med Microbiol Immunol
; 204(4): 493-504, 2015 Aug.
Article
in English
| MEDLINE | ID: mdl-25344657
17.
Sacroiliitis secondary to catheter-related bacteremia due to Mycobacterium abscessus (sensu stricto).
Ann Clin Microbiol Antimicrob
; 13: 9, 2014 Jan 30.
Article
in English
| MEDLINE | ID: mdl-24479655
18.
CFTR p.Arg117His associated with CBAVD and other CFTR-related disorders.
J Med Genet
; 50(4): 220-7, 2013 Apr.
Article
in English
| MEDLINE | ID: mdl-23378603
19.
Multisystemic Effects of Elexacaftor-Tezacaftor-Ivacaftor in Adults with Cystic Fibrosis and Advanced Lung Disease.
Ann Am Thorac Soc
; 2024 Apr 05.
Article
in English
| MEDLINE | ID: mdl-38579175
20.
Highly diverse dynamics of Pseudomonas aeruginosa colonization from initial detection in cystic fibrosis patients: A 7-year longitudinal genetic diversity study.
Infect Genet Evol
; 115: 105513, 2023 11.
Article
in English
| MEDLINE | ID: mdl-37832753